| Midland Care Home Health | |
| 200 Sw Frazier Circle, Topeka, Kansas 66606 | |
| (785) 232-2044 | |
| Name | Midland Care Home Health |
|---|---|
| Location | 200 Sw Frazier Circle, Topeka, Kansas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 178090 |
| Ownership Type | Voluntary Non-profit - Private |
| Service Area Zip Codes | 64111, 66006, 66044, 66046, 66049, 66050, 66066, 66070, 66088, 66402, 66409, 66413, 66414, 66436, 66507, 66512, 66523, 66524, 66526, 66539, 66542, 66546, 66547, 66601, 66603, 66604, 66605, 66606, 66607, 66608, 66609, 66610, 66611, 66612, 66614, 66615, 66616, 66617, 66618, 66619 |
| NPI Number | 1871985689 |
| Organization Name | MIDLAND CARE CONNECTION, INC. |
| Doing Business As | MIDLAND CARE HOME HEALTH |
| Address | 200 Sw Frazier Cir, Topeka, KS 66606 |
| Phone Number | 785-232-2044 |
News Archive
Researchers in the United States have investigated mind wandering in volunteers during a driving simulation.
Research examining the impact of sleep in school-age children suggests that even mild sleep loss produces marked deficits in their cognitive development and functioning.
An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.
› Verified 5 days ago
| Quality Rating: |
News Archive
Researchers in the United States have investigated mind wandering in volunteers during a driving simulation.
Research examining the impact of sleep in school-age children suggests that even mild sleep loss produces marked deficits in their cognitive development and functioning.
An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.2 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 97.2 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 95.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 98.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.9 | 96.4 |
News Archive
Researchers in the United States have investigated mind wandering in volunteers during a driving simulation.
Research examining the impact of sleep in school-age children suggests that even mild sleep loss produces marked deficits in their cognitive development and functioning.
An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 82.1 | 79.6 |
| How often patients got better at getting in and out of bed | 77.5 | 81.1 |
| How often patients got better at bathing | 83.4 | 82.3 |
| How often patients’ breathing improved | 87.1 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 72.3 | 75 |
| How often home health patients had to be admitted to the hospital | 19.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.6 | 94 |
News Archive
Researchers in the United States have investigated mind wandering in volunteers during a driving simulation.
Research examining the impact of sleep in school-age children suggests that even mild sleep loss produces marked deficits in their cognitive development and functioning.
An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.
› Verified 5 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Researchers in the United States have investigated mind wandering in volunteers during a driving simulation.
Research examining the impact of sleep in school-age children suggests that even mild sleep loss produces marked deficits in their cognitive development and functioning.
An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.
› Verified 5 days ago
The patient survey data of Midland Care Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 88 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 89 | 78 |
News Archive
Researchers in the United States have investigated mind wandering in volunteers during a driving simulation.
Research examining the impact of sleep in school-age children suggests that even mild sleep loss produces marked deficits in their cognitive development and functioning.
An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.
› Verified 5 days ago
The University Of Kansas Health System , St. Franc Location: 1915 Sw 6th Avenue, Topeka, Kansas 66606 Ratings: Phone: (785) 295-8240 | |
Caregivers Home Health Location: 2947 Sw Wanamaker Drive, Suite 101, Topeka, Kansas 66614 Ratings: Phone: (785) 354-0767 | |
Carter Healthcare Location: 1725 Sw Gage Blvd. Suite 202, Topeka, Kansas 66604 Ratings: Phone: (785) 329-0275 | |
Encompass Health Home Health Location: 2016 Sw 37th Street, Suite 100, Topeka, Kansas 66611 Ratings: Phone: (785) 232-8593 | |
Midland Care Home Health Location: 200 Sw Frazier Circle, Topeka, Kansas 66606 Ratings: Phone: (785) 232-2044 | |
Interim Healthcare Of Topeka Location: 1251 Sw Arrowhead Suite 103, Topeka, Kansas 66604 Ratings: Phone: (785) 272-1616 |